ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Sen. Mack Seeks Research Funding For Shark Cartilage

July 29, 1994

In Brief: Gifts to NCI Totaled $332,226 In Fiscal 1986; Position Freeze Said To Hurt DCE Labs

January 3, 1986